Kane Matthew R.

President And CEO

1 company

Excellent

Trades Analyzed

12M Win Rate

100.0%

Avg 3M Return

-17.6%

Avg 12M Return

+71.0%

Kane Matthew R. is a President And CEO at PRECISION BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 15 sells.

Estimated insider holdings value: $14.3M based on current market prices.

Holdings by Company

DTILMay 13, 2021

Current Shares2.01M

Value$14.26M

Net Activity-146,227

Bought: 0Sold: 146.2K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 13, 2021	DTIL Precision Biosciences Inc	President And CEO	Sale+OE	9,675	$8.96	$86,688.00	-0.5%	+13.6%	-82.8%
May 10, 2021	DTIL Precision Biosciences Inc	President And CEO	Sale+OE	19,488	$8.41	$163,893.44	-0.5%	+28.6%	-77.0%
Apr 12, 2021	DTIL Precision Biosciences Inc	President And CEO	Sale+OE	9,741	$8.67	$84,454.47	-0.5%	+37.1%	-67.0%
Apr 9, 2021	DTIL Precision Biosciences Inc	President And CEO	Sale+OE	19,473	$8.93	$173,991.19	-0.5%	+32.9%	-66.6%
Mar 12, 2021	DTIL Precision Biosciences Inc	President And CEO	Sale+OE	9,712	$11.36	$110,328.32	-0.5%	-1.3%	-67.2%
Mar 11, 2021	DTIL Precision Biosciences Inc	President And CEO	Sale+OE	19,421	$11.58	$224,992.08	-0.5%	-3.1%	-67.2%
Feb 18, 2021	DTIL Precision Biosciences Inc	President And CEO	Sale+OE	9,705	$12.23	$118,692.15	-0.5%	-	-
Feb 17, 2021	DTIL Precision Biosciences Inc	President And CEO	Sale+OE	19,402	$12.79	$248,147.50	-0.5%	-	-
Jan 26, 2021	DTIL Precision Biosciences Inc	President And CEO	Sale+OE	9,697	$13.37	$129,648.89	-0.5%	-	-
Jan 25, 2021	DTIL Precision Biosciences Inc	President And CEO	Sale+OE	19,913	$13.63	$271,458.84	-0.5%	-	-